Are heart-lung transplant recipients protected from developing transplant coronary artery disease? A case-matched intracoronary ultrasound study

Circulation

Volumn 94, Issue 7, 1996, Pages 1573-1577

  Lim, Tai Tian ^a   Botas, Javier ^a   Ross, Heather ^a   Liang, David H ^a   Theodore, James ^a   Hunt, Sharon A ^a   Oesterle, Stephen N ^a   Yeung, Alan C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery disease; transplantation; ultrasound

Indexed keywords

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL;

EID: 0344231397     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1573     Document Type: Article

References (24)

1. Bieber C, Hunt S, Schwinn D. Complications in long-term survival of cardiac transplantation. Transplant Proc. 1981;8:207-211.
2. Uretsky B, Murali S, Reddy P, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. Development of coronary artery disease in cardiac tranplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987;76:827-834.
3. Billingham ME. Pathology and etiology of chronic rejection of the heart. Clin Transplant. 1994;8:289-292.
4. Baldwin JC, Oyer PE, Stinson EB, Starnes VA, Billingham ME, Shumway NE. Comparison of cardiac rejection in heart and heart-lung transplantation. J Heart Transplant. 1987;6:352-356.
5. Imakita M, Tazelaar HD, Billingham ME. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy. J Heart Transplant. 1986;5:279-285.
6. Jamieson S. Recent developments in heart and heart-lung transplantation. Transplant Proc. 1985;17:199-203.
7. Joshi A, Oyer P, Billingham M. Pathology of the heart in heart-lung transplantation. J Heart Lung Transplant. 1994;13:S34.
8. Richardson M, Pomerance A, Mitchell A, Banner N, Yacoub M. Coronary artery disease in heart-lung transplant recipients: angiographic and histological findings. J Heart Lung Transplant. 1994;13:840.
9. Sarris G, Smith J, Shumway N, Stinson E, Oyer P, Theodore J. Longterm results of combined heart-lung transplantation: the Stanford experience. J Heart Lung Transplant. 1994;13:S40.
10. Liang DH, Schwarzkopf A, Betas J, Alderman EL, Popp RL, Yeung AC. Reproducibility of serial intravascular ultrasound in transplant recipients. Circulation. 1994;90(suppl I):I-639.
11. St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, Stinson EB, Popp RL. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of 'angiographically silent' intimal thickening. Circulation. 1992;85:979-987.
12. Dennis C, Caine N, Sharpies L, Smyth R, Higenbottam T, Stewart S, Wreghitt T, Large S, Wells FC, Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993;12(pt 1): 893-902.
13. Heroux AL, Silverman P, Costanzo MR, O'Sullivan EJ, Johnson MR, Liao Y, McKierman TL, Balhan JE, Leya FS, Mullen GM. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy. Circulation. 1994;89:272-277.
14. Lowry RW, Kleiman NS, Raizner AE, Young JB. Is intravascular ultrasound better than quantitative coronary arteriography to assess cardiac allograft arteriopathy? Cathet Cardiovasc Diagn. 1994; 31:110-115.
15. Pflugfelder PW, Boughner DR, Rudas L, Kostuk WJ. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging. Am Heart J. 1993;125:1583-1591.
16. St Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stinson EB, Billingham ME, Popp RL. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation. 1992;86:756-763.
17. Lowry RW, Kleiman NS, Raizner AE, Young JB. Is intravascular ultrasound better than quantitative coronary arteriography to assess cardiac allograft arteriopathy? Cathet Cardiovasc Diagn. 1994; 31:110-115.
18. Shennib H, Auger JL. Diltiazem improves cyclosporine dosage in cystic fibrosis lung transplant recipients. J Heart Lung Transplant. 1994;13:292-296.
19. Gao SZ, Schroeder JS, Hunt SA, Valantine HA, Hill IR, Stinson EB. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993;12:1029-1035.
20. Schroeder JS, Gao SZ, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med. 1993;328:164-170.
21. Kobashigawa J and the Multicenter Intravascular Ultrasound Group. Does rejection correlate with development of ACAD? results of a multicenter study using ICUS. J Heart Lung Transplant. 1995;14:S16.
22. Kutlu HM, Sadeghi AM, Norton JE, Marboe CC, Smith CR, Reemtsma K, Rose EA. Effect of simultaneous lung transplantation on heart transplant survival in rats. J Heart Transplant. 1987; 6:29-33.
23. Westra AL, Petersen AH, Prop J, Wildevuur CR. The combi-effect reduced rejection of the heart by combined transplantation with the lung or spleen. Transplantation. 1991;52:952-955.
24. Ueki K, Hamano K, Esato K. Immunologically induced coronary artery stenosis in allografts after heart and heart-lung transplantation in rats. Surg Today. 1992;22:191-195.